QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday's pre-market session. The ...

 clearside-to-showcase-versatility-of-scs-microinjector-and-cls-ax-programs-for-retinal-diseases-at-euretina-2025

- Presentations Highlight the Versatility of Clearside's SCS Microinjector® Platform for the Treatment of Multiple Retinal ...

 deal-dispatch-del-taco-tanks-tylenol-maker-aches-for-change-joyebells-burns-the-pie

This week's M&A news includes strategic pivots and stumbles galore, with updates from WK Kellogg, Matador Restaurant an...

 chardan-capital-downgrades-clearside-biomedical-to-neutral

Chardan Capital analyst Daniil Gataulin downgrades Clearside Biomedical (NASDAQ:CLSD) from Buy to Neutral.

 hc-wainwright--co-downgrades-clearside-biomedical-to-neutral-maintains-price-target-to-5

HC Wainwright & Co. analyst Yi Chen downgrades Clearside Biomedical (NASDAQ:CLSD) from Buy to Neutral and maintains the ...

 needham-downgrades-clearside-biomedical-to-hold-announces-3-price-target

Needham analyst Serge Belanger downgrades Clearside Biomedical (NASDAQ:CLSD) from Buy to Hold and announces $3 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION